KingstronBio raised $19.2M Series B venture round, led by Shenzhen Salubris Pharmaceuticals.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$66.1M
Top Valuation
-
KingstronBio raised $19.2M in a Series B round.
The round was announced on 01/01/21.
The round was led by Shenzhen Salubris Pharmaceuticals.